Buscar
Addex Therapeutics Ltd
ADXNAñadir a la lista de seguimiento
5.790USD
+0.120+2.10%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
5.76MCap. mercado
PérdidaP/E TTM
Más Datos de Addex Therapeutics Ltd Compañía
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.
Información de Addex Therapeutics Ltd
Símbolo de cotizaciónADXN
Nombre de la empresaAddex Therapeutics Ltd
Fecha de salida a bolsaMay 22, 2007
Director ejecutivoDyer (Tim)
Número de empleados2
Tipo de seguridadDepository Receipt
Fin del año fiscalMay 22
DirecciónChemin des Mines, 9
CiudadPLAN-LES-OUATES
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postal1202
Teléfono41228841555
Sitio Webhttps://www.addextherapeutics.com/en/
Símbolo de cotizaciónADXN
Fecha de salida a bolsaMay 22, 2007
Director ejecutivoDyer (Tim)
Ejecutivos de Addex Therapeutics Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Addex Therapeutics Ltd?
Los cinco principales accionistas de Addex Therapeutics Ltd son: Mr. Tim Dyer
¿Cuántas instituciones poseen acciones de Addex Therapeutics Ltd (ADXN)?
A fecha de 2026Q1, 8 instituciones poseen acciones de Addex Therapeutics Ltd, con un valor de mercado combinado de aproximadamente 454.00, lo que representa el 0.05% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -12676.00.